We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-6.74%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$82.9B
AUM Growth
-$6.13B
Cap. Flow
+$2.62B
Cap. Flow %
3.16%
Top 10 Hldgs %
28.29%
Holding
7,503
New
382
Increased
2,612
Reduced
3,617
Closed
515

Sector Composition

Rank Sector Weight
1 Healthcare 4.85%
2 Technology 3.93%
3 Financials 3.3%
4 Energy 3.26%
5 Communication Services 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOXX
4751
DELISTED
VOXX International Corporation Class A
VOXX
$69K ﹤0.01%
9,804
-275
-3% -$2.17K
PTR
4752
CALL
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$69K ﹤0.01%
1,000
-1,500
-60% -$134K
AAN.A
4753
DELISTED
The Aaron's Company Inc Class A
AAN.A
$69K ﹤0.01%
1,928
-11,683
-86% -$418K
CMRE icon
4754
Costamare
CMRE
$1.78B
$68K ﹤0.01%
5,700
+5,600
+5,600% +$88.6K
GBT
4755
DELISTED
Global Blood Therapeutics, Inc.
GBT
$68K ﹤0.01%
+1,620
New +$76.4K
CACB
4756
DELISTED
Cascade Bancorp
CACB
$68K ﹤0.01%
13,553
+12,962
+2,193% +$69.3K
PTX
4757
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$68K ﹤0.01%
2,253
+1,225
+119% +$58.6K
EJ
4758
CALL
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$68K ﹤0.01%
13,600
-400
-3% -$2.4K
SPN
4759
PUT
DELISTED
Superior Energy Services, Inc.
SPN
$68K ﹤0.01%
570
+530
+1,325% +$86.6K
ALGN icon
4760
PUT
Align Technology
ALGN
$12.5B
$67K ﹤0.01%
1,200
+500
+71% +$29.8K
AVT icon
4761
PUT
Avnet
AVT
$7.97B
$67K ﹤0.01%
1,600
-1,900
-54% -$79.1K
CADE
4762
DELISTED
Cadence Bank
CADE
$67K ﹤0.01%
2,912
-1,211
-29% -$29.8K
ENS icon
4763
EnerSys
ENS
$7.04B
$67K ﹤0.01%
1,286
-3,776
-75% -$218K
FNB icon
4764
FNB Corp
FNB
$6.85B
$67K ﹤0.01%
5,616
-20,062
-78% -$267K
IWS icon
4765
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$67K ﹤0.01%
1,000
-1,828
-65% -$130K
PHX
4766
DELISTED
PHX Minerals
PHX
$67K ﹤0.01%
4,187
+3,871
+1,225% +$68.7K
WLY icon
4767
John Wiley & Sons Class A
WLY
$2.75B
$67K ﹤0.01%
1,333
-191
-13% -$9.92K
BWP
4768
PUT
DELISTED
Boardwalk Pipeline Partners
BWP
$67K ﹤0.01%
6,100
-1,900
-24% -$25.9K
ITRN icon
4769
Ituran Location and Control
ITRN
$1.11B
$66K ﹤0.01%
3,231
+1,436
+80% +$34.9K
LBTYK icon
4770
PUT
Liberty Global Class C
LBTYK
$3.5B
$66K ﹤0.01%
1,843
-135
-7% -$5.46K
PACB icon
4771
Pacific Biosciences
PACB
$404M
$66K ﹤0.01%
22,214
+20,969
+1,684% +$103K
WST icon
4772
West Pharmaceutical
WST
$24.7B
$66K ﹤0.01%
1,229
-193
-14% -$11.2K
XPP icon
4773
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.85M
$66K ﹤0.01%
1,400
EXPR
4774
CALL
DELISTED
Express, Inc.
EXPR
$66K ﹤0.01%
195
-675
-78% -$254K
GLUU
4775
DELISTED
Glu Mobile Inc.
GLUU
$66K ﹤0.01%
16,545
-60,168
-78% -$309K

Similar funds

Barclays's Q3 2015 Portfolio in Review

As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.

By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.

  • Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
  • Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
  • Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
  • Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
  • Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
  • Barclays opened 382 new positions and closed 515 in Q3 2015.
  • Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.

Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.